Case studies

Global quality — improving quality, reducing compliance issues
The company reduced major quality issues by 40 percent, and generated savings of 15 to 20 percent.
[Read More]

“JumpStarting” Merger Integration Captures Quick Savings
The company increased its savings targets by 30 percent, realized 80 percent of overlapping spend categories, and engaged 90 percent of its combined supply base.
[Read More]

U.K. National Supply Chain Excellence Programme (SCEP) – Generic Drugs Procurement and Management
With minimal interruption to 300 hospitals and savings of ~21 percent, this programme was instrumental in establishing the Category M pricing system for delivering some of the lowest generics pricing globally.
[Read More]

Accelerating and Amplifying R&D Cost Reduction
The pharmaceutical company reduced r&d costs well in excess of targets, with individual areas generating savings from 7 to 60 percent of addressable spend.
[Read More]

East of England Commercial Support Unit
To gain economies of scale in both purchasing and operations, 14 healthcare commissioning organizations engaged A.T. Kearney to design a commercial support unit for procuring and managing central analytic and data solutions.
[Read More]

Manufacturing site improvements lead to 22 percent cost reduction
The plant management team fully committed to an improvement plan that reduced plant conversion cost by 22 percent in two years.
[Read More]

Pharmaceutical Oncology Initiative Partnership (POIP) modeling tool
Chemotherapy units across the UK are now using an innovative, capacity management simulator – C-PORT – which also models the introduction and impact of new cancer regimens and drugs, assists the creation of business plans, simulates the impact of business process changes, and tracks patient waiting times.
[Read More]

Product commercialization for U.S. biotechnology company
At a critical time in its development, a privately-held biotechnology company gained a robust sales forecasting and pricing model, and deal structure for a key diagnostic radiopharmaceutical product.
[read More]

Transformation of UK healthcare insurance provider
A large, private healthcare insurer’s organization was transformed, along with its relationships with hospitals and doctors, to improve management of quality and costs through sourcing healthcare by specialty, thus increasing competition and choice.
[Read More]

Finance/Procurement redesign for a multinational pharmaceutical
With the redesign of their finance organization – including improved processes and task alignment, a multinational pharmaceutical reduced costs while improving service quality to key hospitals, as well as to internal customers in new therapeutic areas.
[Read More]

Supply chain improvements and savings for the UK National Health Service
Over £500 million of savings have been targeted in the NHS supply chain, and with a redesigned procurement organization, they are on the way toward realizing these significant benefits and redirecting the spend toward additional improvements in patient care.
[Read More]